VistaGen Therapeutics, Inc.
VTGN
$3.60
-$0.83-18.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.42M | -15.10M | -13.64M | -14.09M | -12.96M |
| Total Depreciation and Amortization | 185.00K | 169.00K | 166.00K | 161.00K | 157.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 950.00K | 794.00K | 835.00K | 978.00K | 972.00K |
| Change in Net Operating Assets | 4.52M | -4.71M | 2.57M | 2.67M | 946.00K |
| Cash from Operations | -13.76M | -18.85M | -10.06M | -10.28M | -10.89M |
| Capital Expenditure | -60.00K | -65.00K | -88.00K | 0.00 | -61.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.00K | -723.00K | 615.00K | -422.00K | -7.73M |
| Cash from Investing | -94.00K | -788.00K | 527.00K | -422.00K | -7.79M |
| Total Debt Issued | 0.00 | 1.02M | -- | -- | -- |
| Total Debt Repaid | -274.00K | -90.00K | -- | -- | -- |
| Issuance of Common Stock | 27.93M | 558.00K | 1.95M | 1.17M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.65M | 1.49M | 1.95M | 1.17M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.80M | -18.15M | -7.58M | -9.53M | -18.67M |